The pace of change in global healthcare is accelerating and nowhere is this more evident than in the commercialization of new therapies and medical devices. Traditional launch strategies simply can’t keep up.
Here at EVERSANA, we’re exploring new ways to navigate the complexities of launching innovations in this rapidly evolving landscape.
Why Commercialization Needs a New Playbook
Commercialization success now hinges on embracing new models—like Direct-to-Disease (DTD) approaches and AI-enabled tools—that drive efficiency and impact across global markets. As we continue to explore how digital platforms and enabling technologies are transforming the way products are brought to market, learning must be placed at the center of it all is learning to meet patient needs.
Join Us in Berlin This November
These are just a few of the pressing issues we’ll cover at Frontiers Health 2025, a leading health innovation conference held in Berlin on November 11-12.
In a session titled, “Brave New Commercialization World”, Mike Ryan, General Manager, Europe, will be joined by industry experts who are shaping the future of commercialization. The panel promises a lively discussion on the challenges and opportunities facing global launches in 2025 and beyond.
Register Today
Whether you’re a commercialization leader or a digital health innovator, this session is your chance to hear directly from those driving industry change. Don’t miss out! Click here to register for Frontiers Health 2025.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…